Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900276 · ClinicalTrials.gov registry record
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 5
- Enrollment target
NCT00900276: Completed study, sponsored by Wake Forest University Health Sciences.
NCT00900276 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00900276 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and urine from patients with cancer and from healthy participants in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients with kidney cancer or cancer of the urothelium and in healthy participants.
Interventions
- OTHER laboratory biomarker analysis
- OTHER mass spectrometry
- OTHER immunologic technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-04 |
What the finished NCT00900276 record still lists
NCT00900276 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00900276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00900276 about?
NCT00900276 is a clinical study titled "Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants". RATIONALE: Studying samples of blood and urine from patients with cancer and from healthy participants in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients with kidney cancer or cancer of t...
What is the current status of trial NCT00900276?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2006-06. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00900276?
The interventions under investigation include: laboratory biomarker analysis (OTHER), mass spectrometry (OTHER), immunologic technique (OTHER).
Who is sponsoring clinical trial NCT00900276?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia